The global electrophoresis market is projected to grow at a compound annual growth rate (CAGR) of 5.7% from 2023 to 2028, reaching $4.9 billion by the end of the forecast period, according to a new report published by MarketsandMarkets.
Request for Free Sample Report
Electrophoresis is a laboratory technique used to separate DNA, RNA, and protein molecules based on size and charge. The growing use of electrophoresis in proteomic, genomic, and sequencing research across academic institutes and biopharma companies is driving market growth.
North America is expected to continue dominating the global market through 2028 due to substantial government funding for research and public-private partnerships focused on genomics and proteomics. The software tools segment is projected to register the highest CAGR during the forecast period owing to user-friendly workflows for identifying changing proteins.
“Collaborations between life science tool providers and academic researchers are promoting awareness and commercialization of innovative analytical technologies like electrophoresis,” said a senior analyst at MarketsandMarkets. “The demand for personalized medicine therapies in oncology is also fueling R&D activity and electrophoresis adoption.”
Key growth drivers:
- Use of electrophoresis in a widening range of research areas, including drug development, microbiome studies, biomarker analysis, and precision medicine
- Growing number of industry-academia partnerships to increase technology accessibility and commercialize research
- Investments in proteomics and genomics research by biopharma firms and government health agencies
Regional insights:
- North America accounted for the largest revenue share in 2022 due to supportive government policies, developed biopharma sector, and focus on advancing personalized therapies
- Asia Pacific market to exhibit the second highest CAGR during 2023–2028 owing to improving healthcare infrastructure, investments in biomedical research, and favorable regulations
- Europe electrophoresis market to maintain steady growth due to high R&D spending and introduction of advanced instruments by key players
Segment performance:
- Electrophoresis reagents commanded the largest share in 2022, benefiting from recurring purchase of buffers, dyes, and gels
- Software to register highest CAGR during the forecast period, attributed to intuitive analysis features and rising adoption in research workflows
- Research applications segment accounted for over 55% revenue share in 2022, driven by usage in genomics, drug discovery, and molecular biology
Request for Free Sample Report
Competitive landscape: The electrophoresis products market is highly consolidated with leading players such as Thermo Fisher Scientific, Danaher Corporation, Bio-Rad Laboratories, Merck Group, and Agilent Technologies holding majority share. Companies are focused on launching innovative systems, expanding test menus, and pursuing collaborations to strengthen market foothold.